Rite Aid Corporation (NYSE: RAD) today announced sales results for January.
For the four weeks ended Jan. 26, 2013, same store sales increased 0.3 percent over the prior-year period. January front-end same store sales increased 4.2 percent, of which 2.4 percent was attributable to flu-related over-the-counter products. Pharmacy same store sales, which included an approximate 665 basis points negative impact from new generic introductions, decreased 1.4 percent. Prescription count at comparable stores increased 5.0 percent over the prior-year period, of which 3.4 percent was attributable to flu-related prescriptions and flu shots.
Total drugstore sales for the four-week period decreased 0.5 percent to $1.914 billion compared to $1.923 billion for the same period last year. Prescription sales accounted for 68.9 percent of drugstore sales, and third party prescription sales represented 96.2 percent of pharmacy sales.Year-to-Date Sales Same store sales for the 47-week period ended Jan. 26, 2013 increased 0.1 percent over the prior-year period. Front-end same store sales increased 1.6 percent while pharmacy same store sales decreased 0.7 percent. Prescription count at comparable stores increased 3.7 percent over the prior-year period. Total drugstore sales for the 47 weeks ended Jan. 26, 2013 decreased 0.6 percent with sales of $22.826 billion compared to $22.953 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 96.5 percent of pharmacy sales. Rite Aid is one of the nation’s largest drugstore chains. On Jan. 26, 2013, the company operated 4,626 stores compared to 4,672 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision. Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV